<DOC>
	<DOCNO>NCT00560924</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial investigate preventive effect treatment estradiol vaginal tablet recurrent urinary tract infection ( RUTI ) post-menopausal woman sign urogenital age ( UGA ) .</brief_summary>
	<brief_title>Preventive Effect Treatment With Estradiol Vaginal Tablets Recurrent Urinary Tract Infections Post-menopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Postmenopausal woman Urogenital ageing ( UGA ) Recurrent urinary tract infection define three urinary tract infection within past twelve month Known suspect allergy trial product relate product Present UTI History RUTI fertile period life</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>